Crossmark

Incidence, predictors, and outcomes of febrile neutropenia and neutropenia in patients with metastatic castrate-resistant prostate cancer receiving docetaxel

Crossref DOI link: https://doi.org/10.1007/s00520-023-07776-6

Published Online: 2023-05-01

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peltekian, Sophie https://orcid.org/0000-0001-8850-5166
Sajwani, Shellyza https://orcid.org/0000-0003-4189-8964
Wang, Xiang

Kanji, Salmaan https://orcid.org/0000-0003-0594-0360
License Information

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2023-05-01
More Information

Article History

Received: 16 November 2022

Accepted: 21 April 2023

First Online: 1 May 2023

Declarations

:

: Research Ethics Board approval was obtained from the Ottawa Hospital Research Institute with a waiver of consent prior to study commencement (REB #20210171-01H).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below